VG Life Sciences, Inc. Reports On Clinical Outcomes In Phase 1 Cancer Study
Published: Mar 14, 2014
SANTA BARBARA, Calif., March 14, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability and toxicity of its patented technology in patients with advanced stage solid tumors.
Help employers find you! Check out all the jobs and post your resume.